Bottom line
Is APXCX a good fund? The bottom line
APXCX is a managed core / intermediate bond mutual fund from Aristotle.
It charges 0% — about $0 a year on every $10,000 invested, cheaper than 98% of core / intermediate bond funds we track.
With $35.7 million in net assets and 48 holdings, its largest position is RR Ltd (4.2%) and the top 10 make up 33.1% of the portfolio.
What stands out
- Low cost: cheaper than 98% of core / intermediate bond peers
What to watch
- Small fund ($35.7 million) — small funds are likelier to close
Updated Nov 19, 2026
What APXCX invests in
Aristotle Pacific EXclusive Fund Series C (the Fund) seeks to provide total return, primarily consisting of current income.
In pursuing its investment goal, the Fund will primarily invest in securities of collateralized loan obligations (CLOs) issued in the U.S. market that are backed by a pool of non-investment grade senior secured loans and other instruments (such as senior unsecured loans, covenant lite loans (loans which have few or no financial maintenance covenants), subordinated corporate loans and high yield bonds) selected by the CLOs manager. The Fund will principally invest its assets in the mezzanine tranches (generally, notes of CLOs rated by a nationally recognized statistical rating organization or NRSRO between BBB+ and B-) of U.S. broadly syndicated CLOs. The Fund may invest without limit in the junior mezzanine tranches, which are securities rated below investment grade, commonly referred to as high yield or junk bonds and are regarded as speculative with respect to the issuers ability to…
From the fund's prospectus (filed Aug 3, 2026).
What APXCX costs
On a $10,000 investment, APXCX's 0% expense ratio costs about $0 a year. The median core / intermediate bond fund charges 0.71%.
APXCX top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | RR Ltd | 4.21% |
| 2 | Magnetite CLO Ltd | 4.01% |
| 3 | Atlantic Avenue Ltd | 3.94% |
| 4 | OCP Aegis CLO Ltd | 3.40% |
| 5 | CIFC Funding Ltd | 3.37% |
| 6 | Consolidated Communications LL | 2.92% |
| 7 | Barrow Hanley CLO LTD | 2.82% |
| 8 | Apidos CLO | 2.81% |
| 9 | ICG US CLO Ltd | 2.81% |
| 10 | Magnetite CLO Ltd | 2.81% |
Source: SEC Form N-PORT, period ended Jun 30, 2026
The top 10 make up 33.1% of the fund. See all top 25 holdings and asset mix →